BONUS ZERTIFIKAT - BAYER | Market Closed - Deutsche Boerse AG 03:46:40 2024-05-21 pm EDT | ||
| 28.44 EUR | -0.46% |
|
| Current month | +4.81% | ||
| 1 month | +9.25% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
Latest news about BAYER AG
More news
| Date | Price | Change |
|---|---|---|
| 24-05-21 | 28.44 | -0.46% |
| 24-05-20 | 28.57 | 0.00% |
| 24-05-17 | 28.57 | +0.04% |
| 24-05-16 | 28.56 | -2.49% |
| 24-05-15 | 29.29 | -0.48% |
Delayed Quote Deutsche Boerse AG
Last update May 21, 2024 at 03:46 pm EDT
More quotesStatic data
| Product type | Bonus- und Teilschutz-Zertifikate |
|---|---|
| Buy / Sell | CALL |
| Underlying | BAYER AG |
| Issuer | 
Société Générale
|
| WKN | SV4RWY |
| ISIN | DE000SV4RWY2 |
| Date issued | 2023-04-26 |
| Strike | 82 € |
| Maturity | 2024-09-20 (122 Days) |
| Parity | 1 : 1 |
| Emission price | 62.34 € |
| Emission volume | N/A |
| Settlement | Beides |
| Currency | EUR |
Technical Indicators
| Highest since issue | 61.91 € |
|---|---|
| Lowest since issue | 24.97 € |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
28.32
EUR
Average target price
36.9
EUR
Spread / Average Target
+30.34%
- Stock Market
- Certificates
- Certificat